155 related articles for article (PubMed ID: 2089086)
1. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
Oxenkrug GF; Requintina PJ; Yuwiler A
J Neural Transm Suppl; 1990; 32():171-5. PubMed ID: 2089086
[TBL] [Abstract][Full Text] [Related]
2. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
Oxenkrug GF; Requintina PJ; McIntyre IM; White K
J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
[TBL] [Abstract][Full Text] [Related]
3. Chronopharmacological study of moclobemide effect on the rat pineal melatonin biosynthesis.
Oxenkrug GF; Requintina PJ; White K; Yuwiler A
J Neural Transm Suppl; 1994; 41():335-7. PubMed ID: 7931247
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.
Oxenkrug G; McIntyre I; McCauley R; Yuwiler A
J Pineal Res; 1988; 5(1):99-109. PubMed ID: 2452867
[TBL] [Abstract][Full Text] [Related]
5. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
Oxenkrug GF; McCauley RB; Fontana DJ; McIntyre IM; Commissaris RL
J Neural Transm; 1986; 66(3-4):271-80. PubMed ID: 3097249
[TBL] [Abstract][Full Text] [Related]
6. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
Kettler R; Da Prada M; Burkard WP
Acta Psychiatr Scand Suppl; 1990; 360():101-2. PubMed ID: 2248058
[TBL] [Abstract][Full Text] [Related]
7. Regulation of rat pineal melatonin synthesis: effect of monoamine oxidase inhibition.
King TS; Richardson BA; Reiter RJ
Mol Cell Endocrinol; 1982 Mar; 25(3):327-38. PubMed ID: 6279462
[TBL] [Abstract][Full Text] [Related]
8. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
Gerardy J
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
[TBL] [Abstract][Full Text] [Related]
9. Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
Gleiter CH; Nilsson E; Mühlbauer B; Antonin KH; Bieck PR
J Neural Transm Gen Sect; 1992; 89(1-2):129-33. PubMed ID: 1418864
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide, an inhibitor of MAO-A, does not increase daytime plasma melatonin levels in normal humans.
Scheinin M; Koulu M; Vakkuri O; Vuorinen J; Zimmer RH
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):73-82. PubMed ID: 2300680
[TBL] [Abstract][Full Text] [Related]
11. The acute effect of the bioprecursor of the selective brain MAO-A inhibitor, MDL 72392, on rat pineal melatonin biosynthesis.
Oxenkrug GF; Requintina PJ; Yuwiler A; Palfreyman MG
J Neural Transm Suppl; 1994; 41():377-9. PubMed ID: 7931254
[TBL] [Abstract][Full Text] [Related]
12. The effect of MAO-A inhibition and cold-immobilization stress on N-acetylserotonin and melatonin in SHR and WKY rats.
Oxenkrug GF; Requintina PJ
J Neural Transm Suppl; 1998; 52():333-6. PubMed ID: 9564635
[TBL] [Abstract][Full Text] [Related]
13. The response of the pineal melatonin biosynthesis to the selective MAO-A inhibitor, clorgyline, in young and middle-aged rats.
Oxenkrug GF; McIntyre IM; Requintina PJ; Duffy JD
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):895-902. PubMed ID: 1722343
[TBL] [Abstract][Full Text] [Related]
14. 5-Methoxytryptamine is metabolized by monoamine oxidase A in the pineal gland and plasma of golden hamsters.
Raynaud F; Pévet P
Neurosci Lett; 1991 Feb; 123(2):172-4. PubMed ID: 2027530
[TBL] [Abstract][Full Text] [Related]
15. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
[TBL] [Abstract][Full Text] [Related]
16. The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats.
Oxenkrug GF; Requintina PJ; Correa RM; Yuwiler A
J Neural Transm Suppl; 1994; 41():249-52. PubMed ID: 7931233
[TBL] [Abstract][Full Text] [Related]
17. Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide.
Waldmeier PC; Stöcklin K
Eur J Pharmacol; 1990 May; 180(2-3):297-304. PubMed ID: 2365007
[TBL] [Abstract][Full Text] [Related]
18. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
Lavian G; Finberg JP; Youdim MB
Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
[TBL] [Abstract][Full Text] [Related]
19. Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.
Da Prada M; Kettler R; Keller HH; Burkard WP; Haefely WE
J Neural Transm Suppl; 1989; 28():5-20. PubMed ID: 2677242
[TBL] [Abstract][Full Text] [Related]
20. An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration.
Rafii H; Chalon S; Ombetta JE; Frangin Y; Pourcelot L; Besnard JC; Bodard S; Guilloteau D
Life Sci; 1996; 58(14):1159-69. PubMed ID: 8614267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
